Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Thromboxane-induced contractile response of human coronary arterioles is diminished after cardioplegic arrest.

Feng J, Liu Y, Chu LM, Clements RT, Khabbaz KR, Robich MP, Bianchi C, Sellke FW.

Ann Thorac Surg. 2011 Sep;92(3):829-36. doi: 10.1016/j.athoracsur.2011.04.049.

2.

Impaired contractile response of human peripheral arterioles to thromboxane A-2 after cardiopulmonary bypass.

Feng J, Liu Y, Singh AK, Dobrilovic N, Feng WC, Chu LM, Robich MP, Khabbaz KR, Sellke FW.

Surgery. 2011 Aug;150(2):263-71. doi: 10.1016/j.surg.2011.06.004.

3.

Endothelin-1-induced contractile responses of human coronary arterioles via endothelin-A receptors and PKC-alpha signaling pathways.

Feng J, Liu Y, Khabbaz KR, Hagberg R, Sodha NR, Osipov RM, Sellke FW.

Surgery. 2010 Jun;147(6):798-804. doi: 10.1016/j.surg.2009.11.016. Epub 2010 Jan 15.

4.

Mechanisms causing coronary microvascular dysfunction following crystalloid cardioplegia and reperfusion.

Sellke FW, Friedman M, Dai HB, Shafique T, Schoen FJ, Weintraub RM, Johnson RG.

Cardiovasc Res. 1993 Nov;27(11):1925-32.

PMID:
8287398
5.

Serotonin-induced coronary contraction increases after blood cardioplegia-reperfusion: role of COX-2 expression.

Métais C, Li J, Simons M, Sellke FW.

Circulation. 1999 Nov 9;100(19 Suppl):II328-34.

6.
7.

Intramural coronary artery constrictor reactivity to thromboxane is higher in male than in female rats.

Varbiro S, Matrai M, Szekeres M, Nadasy GL, Szaky E, Mericli M, Banhidy F, Monos E, Szekacs B.

Gynecol Endocrinol. 2006 Jan;22(1):44-7.

PMID:
16522533
8.

Altered coronary microvascular serotonin receptor expression after coronary artery bypass grafting with cardiopulmonary bypass.

Robich MP, Araujo EG, Feng J, Osipov RM, Clements RT, Bianchi C, Sellke FW.

J Thorac Cardiovasc Surg. 2010 Apr;139(4):1033-40. doi: 10.1016/j.jtcvs.2009.05.032. Epub 2009 Jul 25.

9.

Thromboxane A2 induces contraction of human prostate smooth muscle by Rho kinase- and calmodulin-dependent mechanisms.

Strittmatter F, Gratzke C, Weinhold P, Steib CJ, Hartmann AC, Schlenker B, Andersson KE, Hedlund P, Stief CG, Hennenberg M.

Eur J Pharmacol. 2011 Jan 15;650(2-3):650-5. doi: 10.1016/j.ejphar.2010.10.052. Epub 2010 Oct 31.

PMID:
21044618
10.

Coronary microvascular protection with mg2+: effects on intracellular calcium regulation and vascular function.

Matsuda N, Tofukuji M, Morgan KG, Sellke FW.

Am J Physiol. 1999 Apr;276(4 Pt 2):H1124-30.

PMID:
10199833
11.

Calcium-activated potassium channels contribute to human coronary microvascular dysfunction after cardioplegic arrest.

Feng J, Liu Y, Clements RT, Sodha NR, Khabbaz KR, Senthilnathan V, Nishimura KK, Alper SL, Sellke FW.

Circulation. 2008 Sep 30;118(14 Suppl):S46-51. doi: 10.1161/CIRCULATIONAHA.107.755827.

12.

Thromboxane A2-induced arrhythmias in the anesthetized rabbit.

Wacker MJ, Best SR, Kosloski LM, Stachura CJ, Smoot RL, Porter CB, Orr JA.

Am J Physiol Heart Circ Physiol. 2006 Apr;290(4):H1353-61. Epub 2005 Dec 9.

PMID:
16339832
13.

Altered expression and activation of mitogen-activated protein kinases in diabetic heart during cardioplegic arrest and cardiopulmonary bypass.

Feng J, Liu Y, Dobrilovic N, Singh AK, Sabe AA, Guan Y, Bianchi C, Sellke FW.

Surgery. 2013 Sep;154(3):436-43. doi: 10.1016/j.surg.2013.05.016.

14.

Decreased coronary microvascular reactivity after cardioplegic arrest in patients with uncontrolled diabetes mellitus.

Feng J, Chu LM, Dobrilovic N, Liu Y, Singh AK, Sellke FW.

Surgery. 2012 Aug;152(2):262-9. doi: 10.1016/j.surg.2012.04.009.

15.

Undiscovered role of endogenous thromboxane A2 in activation of cardiac sympathetic afferents during ischaemia.

Fu LW, Guo ZL, Longhurst JC.

J Physiol. 2008 Jul 1;586(13):3287-300. doi: 10.1113/jphysiol.2007.148106. Epub 2008 May 15.

16.

Inhibition of thromboxane A2-induced arrhythmias and intracellular calcium changes in cardiac myocytes by blockade of the inositol trisphosphate pathway.

Wacker MJ, Kosloski LM, Gilbert WJ, Touchberry CD, Moore DS, Kelly JK, Brotto M, Orr JA.

J Pharmacol Exp Ther. 2009 Dec;331(3):917-24. doi: 10.1124/jpet.109.157677. Epub 2009 Sep 9.

17.

Simultaneously increased TxA(2) activity in isolated arterioles and platelets of rats with hyperhomocysteinemia.

Ungvari Z, Sarkadi-Nagy E, Bagi Z, Szollár L, Koller A.

Arterioscler Thromb Vasc Biol. 2000 May;20(5):1203-8.

18.

Decreased contractile response to endothelin-1 of peripheral microvasculature from diabetic patients.

Feng J, Liu Y, Khabbaz KR, Hagberg R, Robich MP, Clements RT, Bianchi C, Sellke FW.

Surgery. 2011 Feb;149(2):247-52. doi: 10.1016/j.surg.2010.07.003. Epub 2010 Aug 21.

19.

Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists.

Ashton JH, Schmitz JM, Campbell WB, Ogletree ML, Raheja S, Taylor AL, Fitzgerald C, Buja LM, Willerson JT.

Circ Res. 1986 Nov;59(5):568-78.

20.

4-Methylnitrosamino-1-3-pyridyl-1-butanone (NNK) promotes lung cancer cell survival by stimulating thromboxane A2 and its receptor.

Huang RY, Li MY, Hsin MK, Underwood MJ, Ma LT, Mok TS, Warner TD, Chen GG.

Oncogene. 2011 Jan 6;30(1):106-16. doi: 10.1038/onc.2010.390. Epub 2010 Sep 6.

PMID:
20818420

Supplemental Content

Support Center